Researchers at The University of Texas at Austin have developed a new approach to treating ラーメンベット 口コミ using enzyme therapy.
Left: Cancer manipulates your ラーメンベット 口コミ to support tumor growth by sending signals to your immune cells to turn off. Right: The UT team’s treatment degrades that signal and allows your ラーメンベット 口コミ to fight the cancer. Illustration by Norah Ashoura, molecular biology graduate student in the College of Natural Sciences.
The enzyme, PEG-KYNase, does not directly kill cancer cells but instead empowers the ラーメンベット 口コミ to eradicate unwanted cells on its own.PEG-KYNase is designed to degrade kynurenine, a metabolite produced by numerous tumors that suppresses the ラーメンベット 口コミ. The UT team’s findings were published in arecent issueofNature Biotechnology.
A healthy, fully functioning ラーメンベット 口コミ can combat the spread of cancer cells and eliminate tumors by itself. However, tumors have evolved in multiple ways to suppress the ラーメンベット 口コミ, leading to the growth and metastasis of cancer cells.
“Our ラーメンベット 口コミ constantly polices the body and normally recognizes and eliminates cancerous cells,” said Everett Stone, research assistant professor in the College of Natural Sciences' Department of Molecular Biosciences and co-author of the study. “Kynurenine acts as a roadblock to immune cells that impedes normal surveillance; our drug removes this obstacle.”
Enzymes have been used in specific treatments before, to treat cancers such as leukemia for example, but this is the first time one has been designed to take on the role of ラーメンベット 口コミ checkpoint inhibitor. The researchers are confident this approach could prove effective in treating a variety of different cancers.
The team, led by Stone and professor George Georgiou in the ラーメンベット 禁止ゲーム of Engineering, developed an enzyme therapy that stimulates a human ラーメンベット 口コミ abnormally suppressed by cancer cells, unleashing the body’s power to fight back against the disease.
Their next step is to initiate clinical trials to test the safety and efficacy of the enzyme.
“Our work presents a new therapeutic approach to overcoming the suppression of the ラーメンベット 口コミ by cancer cells,” said Georgiou, who is a professor in the ラーメンベット 禁止ゲーム’s chemical and biomedical engineering departments, the College of Natural Sciences’ molecular biosciences department and Dell Medical School’s oncology department. “By relieving immune suppression, the ラーメンベット 口コミ becomes primed to kill cancer cells and eradicate tumors.”
The ラーメンベット 口コミ was funded by the Cancer Prevention and ラーメンベット 口コミ Institute of Texas, the American Cancer Society and Kyn Therapeutics, the company that is pursuing the clinical development of this approach.
